LIFE SCIENCES
Life Sciences 25
Genzyme sought clearance to give adults a cancer drug; Covidien and Depomed reached a license agreement.
| LAST | MARKET CAP | LAST | PCT. | |||
| NO. | WEEK | COMPANY | TICKER | (MILLIONS) | PRICE | CHANGE |
| 1 | 2 | Covidien Ltd. | COV | $18,557 | $36.85 | 10.4% |
| 2 | 1 | Genzyme Corp. | GENZ | $17,319 | $64.02 | -4.3% |
| 3 | 3 | Thermo Fisher Scientific | TMO | $14,993 | $35.68 | 23.5% |
| 4 | 4 | Biogen Idec | BIIB | $12,344 | $42.31 | 6.4% |
| 5 | 5 | Boston Scientific Corp. | BSX | $9,264 | $6.17 | 12.6% |
| 6 | 6 | Waters Corp. | WAT | $4,053 | $41.23 | 18.6% |
| 7 | 7 | Vertex Pharmaceuticals | VRTX | $3,700 | $24.59 | 10.9% |
| 8 | 8 | Hologic | HOLX | $3,603 | $14.06 | 19.9% |
| 9 | 9 | Millipore Corp. | MIL | $2,798 | $50.66 | 13.6% |
| 10 | 10 | PerkinElmer | PKI | $2,133 | $18.06 | 18.3% |
| 11 | 11 | Charles River Laboratories | CRL | $1,543 | $22.80 | 9.7% |
| 12 | 12 | Haemonetics Corp. | HAE | $1,446 | $57.19 | 14.4% |
| 13 | 14 | Cubist Pharmaceuticals | CBST | $1,399 | $24.56 | 11.3% |
| 14 | 15 | Inverness Medical | IMA | $1,373 | $17.57 | 26.6% |
| 15 | 13 | Sepracor | SEPR | $1,280 | $11.76 | 2.4% |
| 16 | 18 | Bruker Corp. | BRKR | $771 | $4.70 | 39.5% |
| 17 | 16 | Alnylam Pharmaceuticals | ALNY | $755 | $18.23 | 0.4% |
| 18 | 17 | Alkermes | ALKS | $703 | $7.38 | 21.0% |
| 19 | 20 | Phase Forward | PFWD | $595 | $13.87 | 42.4% |
| 20 | 19 | AMAG Pharmaceuticals | AMAG | $573 | $33.68 | 22.8% |
| 21 | 21 | Abiomed | ABMD | $514 | $14.04 | 23.6% |
| 22 | 22 | Parexel International Corp. | PRXL | $460 | $8.32 | 26.6% |
| 23 | 23 | Zoll Medical Corp. | ZOLL | $375 | $17.81 | 18.1% |
| 24 | 25 | Momenta Pharmaceuticals | MNTA | $329 | $8.90 | 27.1% |
| 25 | 24 | Idenix Pharmaceuticals | IDIX | $327 | $5.79 | 22.7% |
The Boston Globe/Bloomberg Massachusetts Technology and Life Sciences indexes are price-weighted indexes of all technology and life sciences stocks in the state. Listed above are the top companies, ranked by market value, in each sector. Asterisks indicate a stock that has moved five places or more in the last week. For up-to-the-minute rankings and stock prices, visit boston.com/business. 